Bausch Health
475 hedge funds and large institutions have $38.3B invested in Bausch Health in 2014 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 193 increasing their positions, 151 reducing their positions, and 58 closing their positions.
45% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 58
28% more repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 151
6.69% more ownership
Funds ownership: 83.65% → 90.34% (+6.7%)
5% more funds holding
Funds holding: 452 → 475 (+23)
3% more funds holding in top 10
Funds holding in top 10: 58 → 60 (+2)
8% more call options, than puts
Call options by funds: $1.17B | Put options by funds: $1.07B
4% more capital invested
Capital invested by funds: $36.9B → $38.3B (+$1.45B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Eagle Capital Management (New York)
New York
|
+$481M |
| 2 |
IC
Institutional Capital
Chicago,
Illinois
|
+$452M |
| 3 |
Goldman Sachs
New York
|
+$325M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$323M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$323M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.11B |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$242M |
| 3 |
VAM
Visium Asset Management
New York
|
-$206M |
| 4 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$139M |
| 5 |
JP Morgan Chase
New York
|
-$128M |
BHC Hedge Fund Activity: Q2 2014 in Review
475 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2014, worth a combined $38.3B — up 3.9% from $36.9B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new BHC positions and 58 closed out — a net gain of 26 holders — while 193 added to existing stakes and 151 trimmed.
The largest buyer was Eagle Capital Management (New York), opening a new position worth an estimated $481M. The largest seller was Fidelity Investments, cutting an estimated $1.11B.
- 475 institutional investors held Bausch Health (BHC) as of Q2 2014, up from 452 in Q1 2014.
- Funds reported $38.3B of Bausch Health stock for Q2 2014, up 3.9% quarter-over-quarter.
- 84 funds opened new Bausch Health positions in Q2 2014 and 58 closed out, a net change of +26 holders.
- The largest Bausch Health buyer in Q2 2014 was Eagle Capital Management (New York), an estimated $481M added.
- The largest Bausch Health seller in Q2 2014 was Fidelity Investments, an estimated $1.11B sold.
Based on aggregated 13F filings for Q2 2014.